Villere Equity Fund (VLEQX) is an open-end mutual fund that seeks long-term capital growth through a concentrated, actively managed portfolio primarily invested in small- and mid-cap domestic equity securities. The fund employs a bottom-up research process to select 20 to 30 common stocks of companies with sustainable growth potential at reasonable valuations, unconstrained by benchmarks; it may also allocate to preferred stocks, rights, warrants, and up to 10% in foreign securities via American Depositary Receipts, with current sector exposures including health care (22.5%), financials (19.5%), and consumer discretionary (17.3%). Managed by Villere & Co., a New Orleans-based registered investment adviser founded in 1911 and headquartered at 601 Poydras Street, the fund launched on May 31, 2013, and targets equity investors seeking alternatives to passive strategies in the U.S. market, with assets under management of approximately $36 million and a net expense ratio of 1.07%.
Top holdings as of late 2025 include Ligand Pharmaceuticals (6.4%), Amazon.com (5.5%), Visa (4.6%), Uber Technologies (3.8%), and Stryker (3.8%), representing diverse opportunities across healthcare, technology, financial services, consumer discretionary, and industrials.
The fund operates exclusively through Villere & Co.'s mutual fund platform, available to U.S. investors with a minimum initial investment of $2,000, and complements the firm's broader offerings of separately managed accounts and fixed income strategies for high-net-worth individuals, families, and institutions primarily in the Gulf Coast region. No major acquisitions, partnerships, funding rounds, or strategic shifts have been reported for the fund or Villere & Co. in 2024 or 2025, with focus remaining on selective U.S. equity investments amid ongoing portfolio adjustments for performance.